Distributor DIPO Expands in Costa Rica

Through a new division, DIPO Pharmaceutics (Dipo Farmacéutica), the distribution company will serve the pharmaceutics industry.

Wednesday, March 17, 2010


DIPO has warehouses in Guanacaste, San Carlos, Pérez Zeledón, Pococí and San José. It currently serves 11.000 businesses and plans to serve 1.000 more with the new division.

From Elfinancierocr.com: “Dipo will enter the highly competitive market of medicine distribution. The largest participants are now Cofasa, Grupo Farmanova and Cefa. The latter recently decided to focus in Costa Rica by selling its operations in Honduras and El Salvador”.

More on this topic

Pharmacy Market in Costa Rica Revives

May 2011

Before the arrival of new competitors, pharmaceutical companies are reviewing their strategies for the year.

New premises, training of members and improving operating processes are some of the tactics that will be implemented in the pharmaceutical industry around the country.

The Pharmaceutical Market Shake Up in Costa Rica

May 2013

New distributors, more chain pharmacies and new alliances are examples of the dynamism in the sector.  

One example is the newly founded company KPO Alpha, dedicated to distribution, which has found an interesting market opportunity: independent pharmacies, a business where the partners Leonardo and Maria Acuna, together with their team cater to around 260 shops.

Winners and Losers in Drug Store Wars

July 2012

Corporation Cefa-Fischel is gaining more and more of the market share in Costa Rica, with tactics that are being denounced as anti-competitive business practices.

An article by César Quirós Brenes in Elfinancierocr.com reports on up to what point Cefa-Fischel Corporation has reached in the drug retail sector in Costa Rica: "Of the 950 active pharmacies as of 15 June, 67 (7% of total) are Fischel stores.

High Price of Medicines in Costa Rica

December 2012

A study by the Universidad de Costa Rica notes that one company controls the distribution of 80% of drugs sold, with price differences of up to 1,000%.

An article in Nacion.com reports that there is "little or no competition in the private sector of medicine, product of an industry that is "highly concentrated", causing Costa Rica to have higher drug prices compared to other Central American countries."

 close (x)

Receive more news about Retail

Suscribe FOR FREE to CentralAmericaDATA EXPRESS.
The most important news of Central America, every day.

Type in your e-mail address:

* Al suscribirse, estará aceptando los terminos y condiciones

Investment/partnership in construction of a manufacturing

Construction of a pharmaceutical manufacturing plant. Total cost US$ 2'500'000. We search investors for up to 49%. Includes building, machinery, start-up expenses, operational capital
First year is dedicated to construction. No return. End...

Stock Indexes

(Jun 29)
Dow Jones
S&P 500


(Jun 30)
Brent Crude Oil
Coffee "C"